Cancer-associated cachexia
- PMID: 29345251
- DOI: 10.1038/nrdp.2017.105
Cancer-associated cachexia
Abstract
Cancer-associated cachexia is a disorder characterized by loss of body weight with specific losses of skeletal muscle and adipose tissue. Cachexia is driven by a variable combination of reduced food intake and metabolic changes, including elevated energy expenditure, excess catabolism and inflammation. Cachexia is highly associated with cancers of the pancreas, oesophagus, stomach, lung, liver and bowel; this group of malignancies is responsible for half of all cancer deaths worldwide. Cachexia involves diverse mediators derived from the cancer cells and cells within the tumour microenvironment, including inflammatory and immune cells. In addition, endocrine, metabolic and central nervous system perturbations combine with these mediators to elicit catabolic changes in skeletal and cardiac muscle and adipose tissue. At the tissue level, mechanisms include activation of inflammation, proteolysis, autophagy and lipolysis. Cachexia associates with a multitude of morbidities encompassing functional, metabolic and immune disorders as well as aggravated toxicity and complications of cancer therapy. Patients experience impaired quality of life, reduced physical, emotional and social well-being and increased use of healthcare resources. To date, no effective medical intervention completely reverses cachexia and there are no approved drug therapies. Adequate nutritional support remains a mainstay of cachexia therapy, whereas drugs that _target overactivation of catabolic processes, cell injury and inflammation are currently under investigation.
Similar articles
-
Cancer Cachexia: Definition, Staging, and Emerging Treatments.Cancer Manag Res. 2020 Jul 9;12:5597-5605. doi: 10.2147/CMAR.S261585. eCollection 2020. Cancer Manag Res. 2020. PMID: 32753972 Free PMC article. Review.
-
Tumor cell anabolism and host tissue catabolism-energetic inefficiency during cancer cachexia.Exp Biol Med (Maywood). 2022 May;247(9):713-733. doi: 10.1177/15353702221087962. Epub 2022 May 6. Exp Biol Med (Maywood). 2022. PMID: 35521962 Free PMC article.
-
Revisiting Cancer Cachexia: Pathogenesis, Diagnosis, and Current Treatment Approaches.Asia Pac J Oncol Nurs. 2021 Aug 27;8(5):508-518. doi: 10.4103/apjon.apjon-2126. eCollection 2021 Sep-Oct. Asia Pac J Oncol Nurs. 2021. PMID: 34527780 Free PMC article. Review.
-
Barriers to cancer nutrition therapy: excess catabolism of muscle and adipose tissues induced by tumour products and chemotherapy.Proc Nutr Soc. 2018 Nov;77(4):394-402. doi: 10.1017/S0029665118000186. Epub 2018 Apr 30. Proc Nutr Soc. 2018. PMID: 29708079 Review.
-
Nutritional support in multimodal therapy for cancer cachexia.Support Care Cancer. 2008 May;16(5):447-51. doi: 10.1007/s00520-007-0388-7. Epub 2008 Jan 15. Support Care Cancer. 2008. PMID: 18196284 Review.
Cited by
-
Cancer-Cachexia-Induced Human Skeletal Muscle Myotube Degeneration Is Prevented via Cannabinoid Receptor 2 Agonism In Vitro.Pharmaceuticals (Basel). 2023 Nov 8;16(11):1580. doi: 10.3390/ph16111580. Pharmaceuticals (Basel). 2023. PMID: 38004445 Free PMC article.
-
Exogenous Oncostatin M induces Cardiac Dysfunction, Musculoskeletal Atrophy, and Fibrosis.Cytokine. 2022 Nov;159:155972. doi: 10.1016/j.cyto.2022.155972. Epub 2022 Aug 30. Cytokine. 2022. PMID: 36054964 Free PMC article.
-
Effect of cancer cachexia on first-line chemotherapy in patients with advanced pancreatic cancer: a claims database study in Japan.Int J Clin Oncol. 2024 Apr;29(4):456-463. doi: 10.1007/s10147-024-02467-6. Epub 2024 Feb 14. Int J Clin Oncol. 2024. PMID: 38353906 Free PMC article.
-
Systemic Metabolic and Volumetric Assessment via Whole-Body [18F]FDG-PET/CT: Pancreas Size Predicts Cachexia in Head and Neck Squamous Cell Carcinoma.Cancers (Basel). 2024 Sep 30;16(19):3352. doi: 10.3390/cancers16193352. Cancers (Basel). 2024. PMID: 39409971 Free PMC article.
-
The mortality burden of cachexia or weight loss in patients with colorectal or pancreatic cancer: A systematic literature review.J Cachexia Sarcopenia Muscle. 2024 Oct;15(5):1628-1640. doi: 10.1002/jcsm.13510. Epub 2024 Aug 2. J Cachexia Sarcopenia Muscle. 2024. PMID: 39095951 Free PMC article.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources